Vivity, the world's leading edof iol, reaches one million milestone

Toronto--(business wire)--alcon (six/nyse: alc), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces acrysof® iq vivity® and clareon® vivity extended depth of focus (edof) intraocular lens (iol) has surpassed more than one million implants worldwide. vivity is the most implanted edof iol globally.1* alcon is the global leader in iols—every four seconds an eye is implanted with an alcon iol—and continues to innovate in this space to address patients.
ALC Ratings Summary
ALC Quant Ranking